(Q31113938)

English

Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Eczema vaccinatum as an adverse event following exposure to vaccinia virus: case definition & guidelines of data collection, analysis, and presentation of immunization safety data (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

immunization safety

1 reference

based on heuristic

inferred from title

Eczema vaccinatum

1 reference

based on heuristic

inferred from title

object named as

vaccinia virus

1 reference

based on heuristic

inferred from title

data collection

1 reference

based on heuristic

inferred from title

Katrin Susanne Kohl

2

object named as

Katrin S Kohl

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

author name string

Patricia Nell

1

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Philip L Graham

3

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Philip S LaRussa

4

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

S Michael Marcy

5

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Vincent A Fulginiti

6

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Bryan Martin

7

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Ingrid Trolin

8

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Scott A Norton

9

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

John M Neff

10

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Brighton Collaboration Vaccinia Virus Vaccine Adverse Event Working Group for Eczema Vaccinatum

11

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

language of work or name

0 references

publication date

2 May 2007

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

5725-5734

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Bioterrorism: how prepared are we?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Vaccines in civilian defense against bioterrorism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Dose-related effects of smallpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Clinical responses to undiluted and diluted smallpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Response to smallpox vaccine in persons immunized in the distant past

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

The development of standardized case definitions and guidelines for adverse events following immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Smallpox vaccination: a review, part II. Adverse events

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Risks of smallpox vaccination 200 years after Jenner

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Risks of serious complications and death from smallpox vaccination: a systematic review of the United States experience, 1963-1968

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

ECZEMA VACCINATUM

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Darier's disease: epidemiology, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Darier's disease--the clinical features and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Viral infections in atopic dermatitis Pathogenic aspects and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Smallpox vaccination: Risk considerations for patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Eczematous skin disease and recall of past diagnoses: implications for smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Contact vaccinia--transmission of vaccinia from smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Adverse reactions to smallpox vaccine: the Israel Defense Force experience, 1991 to 1996. A comparison with previous surveys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Treatment of eczema vaccinatum with N-methylisatin beta-thiosemicarbazone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.02.085

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.02.085

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31113938&oldid=1785610564"